Dr Harry has 25 years of experience in executive management of companies in the biotechnology, diagnostic and pharmaceutical sectors. She is a CEO with experience in growing companies from start-up to commercialisation, and has demonstrated expertise in building teams, establishing global partnerships, capital raising, investor relations, together with corporate governance and compliance. He is Chair of Risk and Corporate Governance Committee and member of the Related Parties Committee.
